Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Caris Life Sciences (NASDAQ:CAI) through any online brokerage.
Other companies in Caris Life Sciences’s space includes: Avidity Biosciences Inc (NASDAQ:RNA), Cogent Biosciences Inc (NASDAQ:COGT), Ionis Pharmaceuticals Inc (NASDAQ:IONS), Vaxcyte Inc (NASDAQ:PCVX) and PTC Therapeutics Inc (NASDAQ:PTCT).
Caris Life Sciences has a consensus price target of $34.43.
The stock price for Caris Life Sciences (NASDAQ: CAI) is $27.6 last updated December 16, 2025 at 4:00 PM EST.
There are no upcoming dividends for Caris Life Sciences.
Caris Life Sciences does not have any upcoming earnings scheduled.
There is no upcoming split for Caris Life Sciences.
Caris Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.